Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 58.6M
61.49x5.76x-0.84x5x18.69x25.25x2.81% 298B
23.63x1.98x-14.74x3.24x11.58x19.1x1.68% 69.4B
11.25x11.8x0.07x5.71x8.79x9.52x - 8.9B
17.28x1.49x0.86x2.2x7.54x9x2.59% 8.6B
19.9x5.29x2x5.6x15.84x16.56x-.--% 3.93B
37.33x - 0.24x7.03x20.11x32.58x - 4.34B
37.03x2.21x-1.21x2.09x25.79x38.93x0.83% 3.34B
104.85x - -0.63x - - - -.--% 2.71B
17.21x0.75x-0.63x1.34x24.06x41.19x4.11% 1.06B
51.86x - -0.1x - - - - 1.03B
-7.38x12.16x0.47x202.44x-6.56x-5.12x-.--% 960M
Average 34.04x 5.18x -1.32x 26.07x 13.98x 20.78x 1.5% 33.55B
Weighted average by Cap. 52.02x 5.11x -3.14x 5.12x 16.99x 23.56x 2.53%
Specialty & Advanced Pharmaceuticals